Prevalence of unstable ventricular tachycardia using Holter monitoring in patients with myocardial infarction with cardiac output less than 35%

Prevalence of non-sustained ventricular tachycardia in patients with STEMI with left ventricular ejection fraction (LVEF)<35 using holter monitoring at post-discharge intervals at Chamran hospital and its effect on major adverse cardiac events

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210625051701N1

Enrollment

110

Registered

2021-07-24

Start date

2021-08-11

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevation myocardial infarction (STEMI). ST elevation myocardial infarction (STEMI)

Interventions

Intervention 1: Intervention Intervention group: Patients with myocardial infarction with cardiac output less than 35% undergoing PCI . In the intervention group, forty days after admission, patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 18 years old Consent to enter the study Myocardial infarction (ST-segment elevation of one millimeter or more in at least two adjacent leads) with heart failure (LVEF <35%)

Exclusion criteria

Exclusion criteria: Dissatisfaction with the study Previous history of myocardial infarction Having life-threatening diseases before having a myocardial infarction Patients with left bundle branch block on electrocardiogram Patients with dangerous cardiac conditions who are bedridden Previous history of arrhythmia Previous history of chronic heart failure Monomorphic arrhythmia in the first 24 hours Patients who have undergone CABG Previous history of chronic renal failure

Design outcomes

Primary

Measure	Time frame
Prevalence of NSVT. Timepoint: Every ten days for the first 40 days after discharge. Method of measurement: Holter monitoring.;Incidence of MACE (major cardiac complications including stroke, myocardial infarction and cardiovascular death) in patients. Timepoint: Every ten days for the first 40 days after discharge. Method of measurement: Holter monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfshin Amirpour

Esfahan University of Medical Sciences

Afshinamirpour.ras@gmail.com+98 913 107 2678

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026